Advertisement

SCID Mice Transplanted With Human Cells as Small Animal Models in AIDS Research

  • Caterina Lapenta
  • Stefano M. Santini
  • Massimo Spada
  • Filippo Belardelli
Part of the Infectious Diseases and Pathogenesis book series (IAPA)

Abstract

The progress in AIDS research has been hampered by the lack of a small and practical animal model susceptible to HIV infection, suitable for a rapid testing of antiviral compounds and vaccines. Over the past 20 years, different attempts have been made to develop various models for AIDS in mice. An ensemble of studies carried out in several laboratories during the past decade by using SCID mice transplanted with human cells and infected with HIV have revealed that these chimeric human-mouse models can indeed represent valuable animal systems for addressing a variety of important issues in AIDS research.

Keywords

SCID Mouse Small Animal Model Human PBLs Human Primary Immune Response Human SCID Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albert, S. E., McKerlie, C., Pester, A., Edgell, B. J., Carlyle, J., Petric, M., and Chamberlain, J. W., 1997, Time-dependent induction of protective anti-influenza immune responses in human peripheral blood lymphocyte/SCID mice. Immunology. 159:1393.Google Scholar
  2. Andrus, L., Prince, A. M., Bernal, I., McCormack, P., Lee, D. H., Gorny, M. K., and Zolla-Pazner, S., 1998, Passive immunization with a human immunodeficiency virus type 1-neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant. J Infect Dis. 177:889.PubMedGoogle Scholar
  3. Bentwich, Z., Kalinkovich, A., and Weisman, Z., 1995, Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today. 16:187.PubMedCrossRefGoogle Scholar
  4. Berkowitz, R. D., Alexander, S., and McCune, J. M., 2000, Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus. AIDS Res Hum Retroviruses. 16:1039.PubMedCrossRefGoogle Scholar
  5. Berkowitz, R. D., Beckerman, K. P., Schall, T. J., and McCune, J. M., 1998, CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T-cell differentiation. J Immunol. 161:3702.PubMedGoogle Scholar
  6. Berkowitz, R. D., van’t Wout, A. B., Kootstra, N. A., Moreno, M. E., Linquist-Stepps, V. D., Bare, C., Stoddart, C. A., Schuitemaker, H., and McCune, J. M., 1999, R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4 type pathogenicity in human thymus. J Virol. 73:7817.PubMedGoogle Scholar
  7. Bombil, F., Latinne, D., Kints, J. P., and Bazin, H., 1996, Human recombinant interleukin-4 (HurIL-4) improves SCID mouse reconstitution with human peripheral blood lymphocytes. Immunobiology. 196:437.PubMedGoogle Scholar
  8. Bosma, M. J., and Carroll, A. M., 1991, The SCID mouse mutant: definition, characterization, and potential uses. Ann Rev Immunol. 9:323.CrossRefGoogle Scholar
  9. Boyle, M. J., Connors, M., Flanigan, M. E., Geiger, S. P., Ford, H. Jr., Baseler, M., Adelsberger, J., Davey, R. T. Jr., and Lane, H. C., 1995, The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy. J Immunol. 154:6612.PubMedGoogle Scholar
  10. Clerici, M., Sarin, A., Coffman, R. L., Wynn, T. A., Blatt, S. P., Hendrix, C. W., Wolf, S. F., Shearer, G. M., and Henkart, P. A., 1994, Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci USA. 91:11811.PubMedCrossRefGoogle Scholar
  11. de Quiros, J. C., Shupert, W. L., McNeil, A. C., Gea-Banacloche, J. C., Flanigan, M., Savage, A., Martino, L., Weiskopf, E. E., Imamichi, H., Zhang, Y. M., Adelsburger, J., Stevens, R., Murphy, P. M., Zimmerman, P. A., Hallahan, C. W., Davey, R. T. Jr., and Connors, M., 2000, Resistance to Replication of Human Immunodeficiency Virus Challenge in SCIDHu Mice Engrafted with Peripheral Blood Mononuclear Cells of Nonprogressors Is Mediated by CD8+ T-Cells and Associated with a Proliferative Response to p24 Antigen. J Virol. 74:2023.PubMedCrossRefGoogle Scholar
  12. Delhem, N., Hadida, F., Gorochov, G., Carpentier, F., de Cavel, J. P., Andreani, J. F., Autran, B., and Cesbron, J. Y., 1998, Primary Th1 cell immunization against HIVgp160 in SCIDhu mice coengrafted with peripheral blood lymphocytes and skin. J Immunol. 161:2060.PubMedGoogle Scholar
  13. Di Fabio, S., Giannini, G., Lapenta, C., Spada, M., Binelli, A., Germinario, E., Sestili, P., Belardelli, F., Proietti, E., and Vella, S., 2001, Vaginal transmission of HIV-1 in hu-SCID mice:a new model for the evaluation of vaginal microbicides. AIDS. 15:2231.PubMedCrossRefGoogle Scholar
  14. Duchosal, M. A., McConahey, P. J., Robinson, C. A., and Dixon, F. J., 1990, Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med. 172:985.PubMedCrossRefGoogle Scholar
  15. Fais, S., Lapenta, C., Santini, S. M., Spada, M., Parlato, S., Logozzi, M., Rizza, P., and Belardelli, F., 1999, Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection. J Virol. 73:6453.PubMedGoogle Scholar
  16. Folks, T., Rowe, T., Villinger, F., Parekh, B., Mayne, A., Anderson, D., McClure, H., and Ansari, A. A., 1997, Immune stimulation may contribute to enhanced progression of SIV induced disease in rhesus macaques. J Med Primatol. 26:181.PubMedGoogle Scholar
  17. Garaci, E., Aquaro, S., Lapenta, C., Amendola, A., Spada, M., Covaceuszach, S., Perno, C. F., and Belardelli, F., 2003, Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Proc Natl Acad Sci USA. 100:8927.PubMedCrossRefGoogle Scholar
  18. Gauduin, M. C., Allaway, G. P., Olson, W. C., Weir, R., Maddon, P. J., and Koup, R. A., 1998, CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. J Virol. 72:3475.PubMedGoogle Scholar
  19. Gauduin, M. C., Parren, P. W., Weir, R., Barbas, C. F., Burton, D. R., and Koup, R. A., 1997, Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1. Nat Med. 3:1389.PubMedCrossRefGoogle Scholar
  20. Gauduin, M. C., Safrit, J. T., Weir, R., Fung, M. S., and Koup, R. A., 1995, Pre-and post-exposure protection against human immunodeficiency virus type 1 infection mediated by a monoclonal antibody. J Infect Dis. 171:1203.PubMedGoogle Scholar
  21. Gulizia, R. J., Levy, J. A., and Mosier, D. E., 1996, The envelope gp120 gene of human immunodeficiency virus type 1 determines therate of CD4-positive T-cell depletion in SCID mice engrafted with human peripheral blood leukocytes. J Virol. 70:4184.PubMedGoogle Scholar
  22. Karlsson, G. B., Halloran, M., Schenten, D., Lee, J., Racz, P., Tenner-Racz, K., Manola, J., Gelman, R., Etemad-Moghadam, B., Desjardins, E., Wyatt, R., Gerard, N. P., Marcon, L., Margolin, D., Fanton, J., Axthelm, M. K., Letvin, N. L., and Sodroski, J., 1998, The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med. 188:1159.PubMedCrossRefGoogle Scholar
  23. Khanna, K. V., Whaley, K. J., Zeitlin, L., Moench, T. R., Mehrazar, K., Cone, R. A., Liao, Z., Hildreth, J. E., Hoen, T. E., Shultz, L., and Markham, R. B., 2002, Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest. Jan 109:205.PubMedCrossRefGoogle Scholar
  24. Kish, T. M., Budgeon, L. R., Welsh, P. A., and Howett, M. K., 2001, Immunological characterization of human vaginal xenografts in immunocompromised mice: development of a small animal model for the study of human immunodeficiency virus-1 infection. Am J Pathol. 159:2331.PubMedGoogle Scholar
  25. Lapenta, C., Fais, S., Rizza, P., Spada, M., Logozzi, M. A., Parlato, S., Santini, S. M., Pirillo, M., Belardelli, F., and Proietti, E., 1997, U937-SCID mouse xenografts: a new model for acute in vivo HIV-1 infection suitable to test antiviral strategies. Antiviral Res. 36:81.PubMedCrossRefGoogle Scholar
  26. Lapenta, C., Parlato, S., Spada, M., Santini, S. M., Rizza, P., Logozzi, M., Proietti, E., Belardelli, F., and Fais, S., 1998, Human lymphoblastoid CD4(+) T-cells become permissive to macrophage-tropicstrains of human immunodeficiency virus type 1 after passage into severe combined immunodeficient mice through in vivo upregulation of CCR5: in vivo dynamics of CD4(+) T-cell differentiation in pathogenesis of AIDS. J Virol. 72:10323.PubMedGoogle Scholar
  27. Lapenta, C., Santini, S. M., Logozzi, M., Spada, M., Andreotti, M., Di Pucchio, T., Parlato, S., and Belardelli, F., 2003, Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-a. J Exp Med. 198:361.PubMedCrossRefGoogle Scholar
  28. Lapenta, C., Santini, S. M., Proietti, E., Rizza, P., Logozzi, M., Spada, M., Parlato, S., Fais, S., Pitha, P. M., and Belardelli, F., 1999, Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T-cells from virus-induced depletion in SCID mice transplanted with human cells. Virology. 263:78.PubMedCrossRefGoogle Scholar
  29. Markham, R. B., Schwartz, D. H., Templeton, A., Margolick, J. B., Farzadegan, H., Vlahov, D., and Yu, X. F., 1996, Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells. J Virol. 70:6947.PubMedGoogle Scholar
  30. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M., and Weissman, I. L., 1988, The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 241:1632.PubMedCrossRefGoogle Scholar
  31. McCune, J. M., Namikawa, R., Shih, C. C., Rabin, L., and Kaneshima, H., 1990, Suppression of HIV infection in AZT-treated SCID-hu mice. Science. 247:564.PubMedCrossRefGoogle Scholar
  32. McKinney, D. M., Lewinsohn, D. A., Riddell, S. R., Greenberg, P. D., and Mosier, D. E., 1999, The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets. J Immunol. 163:861.PubMedGoogle Scholar
  33. Mima, T., Saeki, Y., Ohshima, S., Nishimoto, N., Matsushita, M., Shimizu, M., Kobayashi, Y., Nomura, T., and Kishimoto, T., 1995, Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T-cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest. 96:1746.PubMedCrossRefGoogle Scholar
  34. Miura, Y., Misawa, N., Kawano, Y., Okada, H., Inagaki, Y., Yamamoto, N., Ito, M., Yagita, H., Okumura, K., Mizusawa, H., and Koyanagi, Y., 2003, Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci USA. 100:2777.PubMedCrossRefGoogle Scholar
  35. Miura, Y., Misawa, N., Maeda, N., Inagaki, Y., Tanaka, Y., Ito, M., Kayagaki, N., Yamamoto, N., Yagita, H., Mizusawa, H., and Koyanagi, Y., 2001, Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T-cells in HIV-1-infected hu-PBL-NOD-SCID mice. J Exp Med. 193:651.PubMedCrossRefGoogle Scholar
  36. Mosier, D. E., 1996, Humanizing the mouse. Semin Immunol. 8:185.CrossRefGoogle Scholar
  37. Mosier, D. E., Gulizia, R. J., Baird, S. M., and Wilson, D. B., 1988, Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 335:256.PubMedCrossRefGoogle Scholar
  38. Mosier, D. E., Gulizia, R. J., Baird, S. M., Wilson, D. B., Spector, D. H., and Spector, S. A., 1991, Human immunodeficiency virus infection of human-PBL-SCID mice. Science. 251:791.PubMedCrossRefGoogle Scholar
  39. Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Corey, L., and Greenberg, P. D., 1993, Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160. Proc Natl Acad Sci USA. 90:2443.PubMedCrossRefGoogle Scholar
  40. Mosier, D. E., Gulizia, R. J., MacIsaac, P. D., Torbett, B. E., and Levy, J. A., 1993, Rapid loss of CD4+ T-cells in human-PBL-SCID mice by noncytopathic HIV isolates. Science. 260: 689.PubMedCrossRefGoogle Scholar
  41. Nakao, R., Hanada, N., Asano, T., Hara, T., Abdus Salam, M., Matin, K., Shimazu, Y., Nakasone, T., Horibata, S., Aoba, T., Honda, M., Amagasa, T., and Senpuku, H., 2003, Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte. Immunology. 109:271.PubMedCrossRefGoogle Scholar
  42. Picchio, G. R., Valdez, H., Sabbe, R., Landay, A. L., Kuritzkes, D. R., Lederman, M. M., and Mosier, D. E., 2000, Altered viral fitness of HIV-1 following failure of protease inhibitorbased therapy. J Acquir Immune Defic Syndr. 25:289.PubMedCrossRefGoogle Scholar
  43. Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W., Mosier, D. E., and Burton, D. R., 1999, Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity. 10:431.PubMedCrossRefGoogle Scholar
  44. Poluektova, L. Y., Munn, D. H., Persidsky, Y., and Gendelman, H. E., 2002, Generation of cytotoxic T-cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol. 168:3941.PubMedGoogle Scholar
  45. Rizza, P., Santini, S. M., Logozzi, M. A., Lapenta, C., Sestili, P., Gherardi, G., Lande, R., Spada, M., Parlato, S., Belardelli, F., and Fais, S., 1996, T-cell dysfunction in hu-PBL-SCID mice infected with Human Immunodeficiency Virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells. J Virol. 70:7958.PubMedGoogle Scholar
  46. Saeki, Y., Mima, T., Sakoda, S., Fujimura, H., Arita, N., Nomura, T., and Kishimoto, T., 1992, Transfer of multiple sclerosis into severe combined immunodeficiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc Natl Acad Sci USA. 89:6157.PubMedCrossRefGoogle Scholar
  47. Safrit, J. T., Fung, M. S., Andrews, C. A., Braun, D. G., Sun, W. N., Chang, T. W., and Koup, R. A., 1993. Hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120. AIDS. 7:15.PubMedCrossRefGoogle Scholar
  48. Santini, S. M., Lapenta, C., Logozzi, M., Parlato, S., Spada, M., Di Pucchio, T., and Belardelli, F., 2000, Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 191:1777.PubMedCrossRefGoogle Scholar
  49. Scoggins, R. M., Taylor, J. R. Jr., Patrie, J., van’t Wout, A. B., Schuitemaker, H., and Camerini, D., 2000, Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice. J Virol. 74:3205.PubMedCrossRefGoogle Scholar
  50. Somasundaram, R., Jacob, L., and Herlyn, D., 1995, Tetanus toxoid-specific T-cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytes. Clin Exp Immunol. 101:94.PubMedCrossRefGoogle Scholar
  51. Sousa, A. E., Carneiro, J., Meier-Schellersheim, M., Grossman, Z., and Victorino, R. M., 2002, CD4 T-cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol. 169:3400.PubMedGoogle Scholar
  52. Stevenson, M., Stanwick, T. L., Dempsey, M. P., and Lamonica, C. A., 1990, HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J. 9:1551.PubMedGoogle Scholar
  53. Tary-Lehmann, M., and Saxon, A., 1992, Human mature T-cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med. 175:503.PubMedCrossRefGoogle Scholar
  54. Tary-Lehmann, M., Saxon, A., and Lehmann, P. V., 1995, The human immune system in hu-PBL-SCID mice. Immunol Today. 16:529.PubMedCrossRefGoogle Scholar
  55. Van Kuyk, R., Torbett, B. E., Gulizia, R. J., Leath, S., Mosier, D. E., and Koenig, S., 1994, Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism. J Immunol. 153:4826.PubMedGoogle Scholar
  56. Vieillard, V., Jouveshomme, S., Leflour, N., Jean-Pierre, E., Debre, P., De Maeyer, E., and Autran, B., 1999, Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection. J Virol. 73:10281.PubMedGoogle Scholar
  57. Wang, C. Y., Sawyer, L. S., Murthy, K. K., Fang, X., Walfield, A. M., Ye, J., Wang, J. J., Chen, P. D., Li, M. L., Salas, M. T., Shen, M., Gauduin, M. C., Boyle, R. W., Koup, R. A., Montefiori, D. C., Mascola, J. R., Koff, W. C., and Hanson, C. V., 1999, Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex. Proc Natl Acad Sci USA. 96:10367.PubMedCrossRefGoogle Scholar
  58. Wang, E. J., Pettoello-Mantovani, M., Anderson, C. M., Osiecki, K., and Moskowitz, D., 2002, Goldstein, H., Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type1-infected cells. J Infect Dis. 186:1412.PubMedCrossRefGoogle Scholar
  59. Wang, E. J., Pettoello-Mantovani, M., Anderson, C. M., Osiecki, K., Moskowitz, D., and Goldstein, H., 2002, Development of a novel transgenic mouse/SCID-hu mouse system to characterize the in vivo behavior of reservoirs of human immunodeficiency virus type 1-infected cells J Infect Dis. 186:1412.PubMedCrossRefGoogle Scholar
  60. Zhang, C., Cui, Y., Houston, S., and Chang, L. J., 1996, Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. Proc Natl Acad Sci USA. 93:14720.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Caterina Lapenta
    • 1
  • Stefano M. Santini
    • 1
  • Massimo Spada
    • 1
  • Filippo Belardelli
    • 1
  1. 1.Department of Cell Biology and NeuroscienceIstituto Superiore di SanitàRomeItaly

Personalised recommendations